2,4-Dichloro-7-fluoro­quinazoline

The mol­ecule of the title compound, C8H3Cl2FN2, is essentially planar, with a maximum deviation of 0.018 (2) Å. In the crystal, π–π stacking is observed between parallel quinazoline moieties of adjacent mol­ecules, the centroid–centroid distance being 3.8476 (14) Å

N-Methyl-4-nitro­anilinium chloride

The asymmetric unit of the title salt, C7H9N2O2 +·Cl−, contains two independent cations and anions. In the crystal, each N-methyl-4-nitro­anilinium cation is linked to two Cl− anions via N—H⋯Cl hydrogen bonds. π–π stacking is observed between the benzene rings of adjacent cations [centroid-to-centroid distances = 3.7684 (14) and 3.7917 (7) Å]

Ukupna kinetika redukcije niskokvalitetnog piroluzita smjesom hemiceluloze i lignina kao redukcijskog sredstva

Manganese is widely used in many fields. Many efforts have been made to recover manganese from low-grade pyrolusite due to the depletion of high-grade manganese ore. Thus, it is of practical significance to develop a clean, energy-saving and environmentally friendly technical route to reduce the low-grade pyrolusite. The reported results show that biomass wastes from crops, crop waste, wood and wood waste are environmentally friendly, energy-saving, and low-cost reducing agents for roasting reduction of low-grade pyrolusite. Kinetics of the reduction reactions is necessary for an efficient design of biomass reduction of pyrolusite. Therefore, it is important to look for a general kinetics equation to describe the reduction of pyrolusite by different kinds of biomass, because there is a wide variety of biomass wastes, meaning that it is impossible to investigate the kinetics for each biomass waste. In this paper, thermal gravimetric analysis and differential thermal analysis were applied to study the overall reduction kinetics of pyrolusite using a mixture of hemicellulose and lignin, two major components of biomass. Overall reduction process is the overlap of the respective reduction processes. A new empirical equation based on the Johnson–Mehl–Avrami equation can be used to describe the respective reduction kinetics using hemicellulose and lignin as reductants, and the corresponding apparent activation energy is 30.14 kJ mol−1 and 38.91 kJ mol−1, respectively. The overall kinetic model for the reduction of pyrolusite by the mixture of hemicellulose and lignin can be simulated by the summation of the respective kinetics by considering their mass-loss fractions, while a unit step function was used to avoid the invalid conversion data. The obtained results in this work are necessary to understand the biomass reduction of pyrolusite and provide valuable assistance in the development of a general kinetics equation.Ukupna kinetika redukcije piroluzita istraživana je termogravimetrijom i diferencijalnom termogravimetrijom. Kao redukcijsko sredstvo upotrijebljeni su hemiceluloza i lignin, glavni sastojci poljoprivrednog biljnog biootpada, drva i drvnog otpada. Ukupnu redukciju čine isprepleteni pojedinačni redukcijski procesi. Kinetika redukcije piroluzita smjesom hemiceluloze i lignina može se opisati novom empirijskom jednadžbom temeljenoj na jednadžbi Johnson–Mehl–Avrami, a odgovarajuća prividna energija aktivacije iznosi 30.14 kJ mol−1, odnosno 38.91 kJ mol−1. Sveobuhvatna kinetika može se modelirati kao zbroj pojedinačnih udjela uzimajući u obzir masene udjele sastojaka smjese te uz primjenu jedinične odskočne funkcije kako bi se izbjegli nevaljani podaci

Moving Target Detection and Active Tracking with a Multicamera Network

We propose a systematic framework for Intelligence Video Surveillance System (IVSS) with a multicamera network. The proposed framework consists of low-cost static and PTZ cameras, target detection and tracking algorithms, and a low-cost PTZ camera feedback control algorithm based on target information. The target detection and tracking is realized by fixed cameras using a moving target detection and tracking algorithm; the PTZ camera is manoeuvred to actively track the target from the tracking results of the static camera. The experiments are carried out using practical surveillance system data, and the experimental results show that the systematic framework and algorithms presented in this paper are efficient

Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model

In recent years, oncolytic viruses have attracted increasing interest due to their potent antitumor effects. Luteolin, a natural product, has additionally been observed to exhibit various pharmacological antitumor activities. Previously, a novel dual-targeting oncolytic adenovirus, complement decay-accelerating factor (CD55)-tumor necrosis factor ligand superfamily member 10 (TRAIL), was constructed, which exhibited significant growth inhibitory effects in various types of tumor cell. The present study investigated whether the combination of luteolin and CD55-TRAIL was able to exert a synergistic antitumor effect in colorectal carcinoma (CRC) cells. The cytotoxicity and tumor cell apoptosis mediated by combination treatment in CRC cells were detected via an MTT assay, Hoechst staining and western blotting, respectively. Tumor growth in vivo was examined in a CRC mouse xenograft model following various treatments. The results demonstrated that the addition of luteolin enhanced oncolytic adenovirus-mediated enhanced green fluorescent protein, early region 1A and TRAIL expression. The combination of CD55-TRAIL with luteolin synergistically inhibited tumor growth and promoted CRC cellular apoptosis in vitro and in vivo. Additionally, the combination of CD55-TRAIL with luteoli n significa ntly decrea sed cy totoxicit y in lung/bronchial normal epithelial cells, compared with single treatment

Arterial occlusion to treat basilar artery dissecting aneurysm

Object To explore the clinical feasibility of employing occlusion to treat basilar artery dissecting aneurysm. Methods One patient, male and 46 years old, suffered transient numbness and weakness on the right limbs. Cerebral angiography indicated basilar artery dissecting aneurysm. The patient underwent the stent-assisted coil embolization of aneurysm and the result is satisfactory. Digital subtraction angiography (DSA) reviews were performed at 1 month and 4.5 months, respectively after the operation and indicate that the basilar artery is unobstructed and there was no recurrence of the aneurysm. DSA review 1 year after the first treatment indicates the aneurysm recurrence, stent-assisted coils dense embolization of aneurysm was performed again and the result was satisfactory. Ten months after the second operation, DSA review found the basilar artery aneurysm recurrence again and occlusion of the basilar artery was performed. Results The basilar artery occlusion was effective. The bilateral posterior inferior cerebellar arteries and the bilateral posterior cerebral arteries are unobstructed. Five months of follow-up found that the patient recovered well. DSA reviews performed 5 months after occlusion indicate no recurrence of the aneurysm. Conclusions Occlusion to treat basilar artery dissecting aneurysm is clinically feasible, but surgical indications should be considered strictly

A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation

Background: Non-vitamin K antagonist oral anticoagulants (NOACs) depend on some degree of renal excretion, and no head-to-head comparisons based on renal function is available. This study mainly investigated the trade-off property of NOACs in nonvalvular atrial fibrillation (NVAF) with varying degrees of renal function.Methods: A comprehensive search of Medline, Embase, Cochrane Library, and Clinical Trials.gov Website was performed for eligible randomized controlled trials (RCTs) that reported the efficacy and safety outcomes according to renal function of NOACs. Primary efficacy outcome was any Stroke or systemic embolism (S/SE). Major bleeding was considered as a primary safety outcome. Risk ratios (RRs) with their confidence intervals (CIs), the surface under the cumulative ranking curve (SUCRA), and trade-off analysis were conducted by renal function.Results: Finally, 5 phase III Clinical Trials (72961 NVAF patients) comparing NOACs with warfarin in NVAF patients were included. In terms of normal renal function, dabigatran-150 mg was ranked first for efficacy (SUCRA: 90.3), and edoxaban-30 mg was ranked first for safety (SUCRA: 93.3). Dabigatran-110 mg/150 mg, and apixaban-5 mg were regarded as the most effective and reasonably safe interventions in the trade-off analysis. Regarding mild renal impairment, edoxaban-60 mg was ranked first for efficacy (SUCRA: 97.8), and edoxaban-30 mg was ranked first for safety (SUCRA: 99.5). Edoxaban-60 mg and dabigatran-150 mg were accounted as the most effective and reasonably safe interventions. With regards to moderate renal impairment, dabigatran-150 mg was ranked first for efficacy (SUCRA: 95.1), and edoxaban-15 mg was ranked first for safety (SUCRA: 98.2). Apixaban-2.5 mg and Edoxaban-30 mg was considered as the reasonably effective and the safest interventions.Conclusions: Dabigatran-150 mg seems the most effective therapy in patients with normal renal function and moderate renal impairment, and edoxaban-60 mg in patients with mild renal impairment. Low dose edoxaban (15 and 30 mg) seems the safest intervention. Apixaban-2.5 mg and edoxaban-30 mg might be the best trade-off property in moderate renal insufficiency.HIGHLIGHTS Dabigatran-150 mg seems the most effective therapy for normal renal function and moderate renal impairment patients, edoxaban-60 mg for mild renal impairment patients.Low-dose edoxaban can be considered as a good choice in NVAF patients at high risk of bleeding.Apixaban-2.5 mg and edoxaban-30 mg might be the balanced option in NVAF patients with moderate renal insufficiency.STUDY REGISTRATION: PROSPERO Identifier, CRD42017054235